Calmark receives order from Egypt

Calmark receives order from Egypt

Calmark Sweden AB (publ) announces today that the Company has received an order from the distributor in Egypt, Enox Pharma AB, covering the Calmark Neo platform and bilirubin tests. The economic value of today's order is of minor importance, but it is important from a launch perspective.

As previously disclosed, an exclusive distributor agreement has been signed with the company Enox Pharma AB regarding marketing and sales of Calmark's products in the countries Egypt, Iraq, Bahrain, Saudi Arabia and the United Arab Emirates.

“I am happy for the order which shows that our distributor now started active sales work also in Egypt,” says Magdalena Tharaldsen, Director International Business Development at Calmark. “Enox Pharma is a fantastic distributor with headquarter in Sweden and local experts with extensive knowledge and expertise of each individual country circumstances. Our products will be demonstrated at the Femi Health Forum in Cairo on September 18-19.”

This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 19 August 2021, 10:10 CEST.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.